Iskander, Safwat

Iskander, Safwat was paid $4.15M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 49% of everything it billed.

33Billing provider infoISKANDER, SAFWAT
KANKAKEE, IL 60901

33aNPI1194781112assigned 04/26/2006

33bProvider typePediatrics Physician

28Total paid$4.15M

24GClaims84,435

24DCodes billed45

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pediatrics Physician providers in Illinois

Rank by total paid#13 of 1,805

Median peer was paid$55K

This provider vs. median75×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,873	$405K
2019	13,198	$591K
2020	10,956	$511K
2021	9,637	$519K
2022	15,272	$752K
2023	12,892	$655K
2024incomplete	13,607	$713K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	49%	26,803	22,053	$2.04M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	13,295	10,935	$642K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	7.1%	3,861	3,444	$296K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	5.8%	3,494	3,105	$239K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	4.7%	4,814	4,410	$196K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	3.9%	5,421	4,724	$161K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	3.8%	2,071	1,946	$157K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	3.0%	1,496	1,410	$125K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.1%	2,996	2,716	$45K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	1,898	1,737	$30K
90670		<1%	2,296	2,015	$24K
90698		<1%	2,004	1,759	$22K

33 more codes

87807		<1%	2,194	$21K
90686		<1%	1,527	$16K
90744		<1%	1,317	$15K
90633		<1%	1,116	$13K
99222	Initial hospital care, per day, moderate complexity	<1%	222	$13K
90651		<1%	685	$12K
90681		<1%	897	$10K
99238	Hospital discharge day management, 30 minutes or less	<1%	270	$9K
90734		<1%	533	$8K
90677		<1%	414	$7K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	452	$6K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	453	$6K
90710		<1%	373	$5K
90715		<1%	403	$5K
90619		<1%	234	$4K
99381		<1%	43	$4K
90696		<1%	260	$3K
99232	Hospital visit by a doctor, follow-up day	<1%	107	$3K
90648		<1%	253	$2K
90656		<1%	124	$2K
90707		<1%	97	$1K
81002		<1%	407	$972.40
83655		<1%	86	$919.15
90716		<1%	76	$883.64
A7015	Aerosol mask, used with dme nebulizer	<1%	468	$699.60
90723		<1%	93	$602.40
85018		<1%	248	$568.40
90685		<1%	71	$478.82
36416		<1%	84	$336.20
90680		<1%	15	$96.00
94760		<1%	14	$61.60
99051		<1%	138	$20.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	312	$14.34

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.